U.K. starts construction on cell line manufacturing facility; Orlando area offers incentives for sterile manufacturing facility;

> The Cell Therapy Catapult in the U.K. has started construction on its £55 million ($84 million) cell and gene therapy manufacturing site in Stevenage. Release

> Pharmapack Europe looks to wrap up the award nomination process. Release

> Florida's Osceola County wants to give $640,000 in incentives to "Project Genuine" to attract an unnamed sterile injectables maker to the Orlando area. Story

Suggested Articles

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

Pfizer struck a deal to produce Gilead Sciences' remdesivir, which has been running short at some hard-hit U.S. hospitals.

On the heels of last week's deal for 120 million Pfizer-BioNTech shots, Japan has locked down 120 million more vaccines from AstraZeneca.